CD8A and neoplasm: We previously reported that Rab37 acts as a tumor promoter in macrophages by mediating IL-6 secretion to activate M2 macrophage polarization and reprogram PD-1+CD8+ exhausted T cells, ultimately fostering an immunosuppressive TME 23.